beta
ROSG
Rosetta Genomics Ltd.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Rosetta Genomics Ltd is engaged in the development and commercialization of new diagnostic products based on a recently discovered group of genes known as microRNAs. MicroRNAs are naturally expressed, or produced, using instructions encoded in DNA.
Market Cap: 3.49 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.rosettagenomics.com
Shares Outstanding: 5.93 Million
Float: 5.93 Million
Dividend: 0.0 (0.0%)
Beta: 0.387398
Sector: Healthcare
Industry: Medical Diagnostics & Research
Ethical Flags
Longest drawdown: 1050 trading days
From: 2014-03-20 To: 2018-05-21
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-03-17 | 12.0 | 1.0 | 12.0 |